Fidelity Investments
CGEM icon

Fidelity Investments’s Cullinan Oncology CGEM Stock Holding History

Fidelity Investments’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.37M Buy
240,115
+232,883
+3,220% +$3.46M ﹤0.01% 2462
2026
Q1 		$103K Buy
7,232
+2,634
+57% +$33.9K ﹤0.01% 3783
2025
Q4 		$47.6K Buy
4,598
+3,630
+375% +$32.7K ﹤0.01% 4141
2025
Q3 		$5.74K Sell
968
-2,844
-75% -$20.8K ﹤0.01% 4754
2025
Q2 		$28.7K Buy
3,812
+1,253
+49% +$10.1K ﹤0.01% 4142
2025
Q1 		$19.4K Sell
2,559
-40,233
-94% -$386K ﹤0.01% 4232
2024
Q4 		$521K Buy
42,792
+22,432
+110% +$322K ﹤0.01% 2911
2024
Q3 		$341K Buy
20,360
+19,681
+2,899% +$349K ﹤0.01% 3004
2024
Q2 		$11.8K Buy
679
+153
+29% +$3.26K ﹤0.01% 4272
2024
Q1 		$8.96K Buy
526
+84
+19% +$1.3K ﹤0.01% 4318
2023
Q4 		$4.5K Sell
442
-1,132
-72% -$10K ﹤0.01% 4482
2023
Q3 		$14.2K Sell
1,574
-53,348
-97% -$556K ﹤0.01% 3972
2023
Q2 		$591K Buy
54,922
+650
+1% +$6.9K ﹤0.01% 2605
2023
Q1 		$555K Sell
54,272
-34,114
-39% -$376K ﹤0.01% 2657
2022
Q4 		$932K Sell
88,386
-41,148
-32% -$500K ﹤0.01% 2559
2022
Q3 		$1.66M Sell
129,534
-84,532
-39% -$1.14M ﹤0.01% 2477
2022
Q2 		$2.74M Sell
214,066
-1,415,114
-87% -$16M ﹤0.01% 2408
2022
Q1 		$17.1M Buy
1,629,180
+689,140
+73% +$9.31M ﹤0.01% 1855
2021
Q4 		$14.5M Sell
940,040
-1,560,172
-62% -$31.1M ﹤0.01% 1968
2021
Q3 		$56.4M Buy
2,500,212
+522,305
+26% +$14M ﹤0.01% 1361
2021
Q2 		$50.9M Buy
1,977,907
+757,733
+62% +$23.3M ﹤0.01% 1420
2021
Q1 		$50.8M Buy
+1,220,174
New +$49.5M ﹤0.01% 1393

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Fidelity Investments's CGEM Position: Q2 2026 in Review

Fidelity Investments increased its Cullinan Oncology (CGEM) stake by 3,220% in Q2 2026, buying an estimated $3.46M and bringing the position to 240,115 shares worth $4.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2462.

Fidelity Investments first reported a position in CGEM in Q1 2021 and has held it in 22 quarters since. The position peaked at $56.4M in Q3 2021. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Fidelity Investments held 240,115 shares of Cullinan Oncology worth $4.37M as of Q2 2026.
  • Fidelity Investments bought 232,883 Cullinan Oncology shares in Q2 2026, an estimated $3.46M.
  • Cullinan Oncology made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2462 holding.
  • Fidelity Investments first reported a position in Cullinan Oncology in Q1 2021 and has held it in 22 quarters since.
  • Fidelity Investments's Cullinan Oncology position peaked at $56.4M in Q3 2021.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.